Showing 7,841 - 7,860 results of 10,396 for search '(( significant factor decrease ) OR ( significant ((changes decrease) OR (largest decrease)) ))', query time: 0.70s Refine Results
  1. 7841

    Table 7_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …”
  2. 7842

    Table 2_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xls by Baodong Wang (3359171)

    Published 2025
    “…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …”
  3. 7843

    Image 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.tif by Baodong Wang (3359171)

    Published 2025
    “…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …”
  4. 7844

    Table 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…Finally, it is forecasted that the smoking-related LBP burden will decrease from 2022 to 2036.</p>Conclusion<p>From 1990 to 2021, the global ASDR of LBP attributable to smoking decreased, and this downward trend is expected to persist. …”
  5. 7845

    Table 6_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  6. 7846

    Table 2_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  7. 7847

    Table 7_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  8. 7848

    Image 1_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.tif by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  9. 7849

    Image 2_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.tif by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  10. 7850

    Table 1_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  11. 7851

    Table 3_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  12. 7852

    Supplementary file 1_Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis.docx by Ping Qi (772738)

    Published 2025
    “…</p>Results<p>(1) Gut microbiota showed no α-diversity difference between groups, but β-diversity differed significantly. PVT patients had increased Gram-negative bacteria (such as Escherichia-Shigella) and decreased SCFA-producing taxa. (2) Compared with peripheral vein microbiota, portal vein microbiota showed significant difference in α diversity and β diversity in cirrhotic patients with PVT, with Massilia enriched. (3) Portal microbiota had the highest diagnostic value for PVT (AUC = 0.95). (4) The tPVT group had more portal-feces shared genera than the tNPVT group (49 vs. 29). …”
  13. 7853

    Table 5_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  14. 7854

    Table 4_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

    Published 2025
    “…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”
  15. 7855

    Image 1_Bright light exposure reduces negative affect and modulates EEG activity in sleep-deprived and well-rested adolescents.tif by Jana Kopřivová (14754945)

    Published 2025
    “…Behavioral and EEG effects were similar across groups; however, only in the sleep-deprived group changes in beta activity significantly correlated with reduced negative affect.…”
  16. 7856

    Data Sheet 1_Proteome analysis of the prefrontal cortex and the application of machine learning models for the identification of potential biomarkers related to suicide.pdf by Manuel Alejandro Rojo-Romero (20756459)

    Published 2025
    “…Introduction<p>Suicide is a significant public health problem, with increased rates in low- and middle-income countries such as Mexico; therefore, suicide prevention is important. …”
  17. 7857

    Image 1_Dietary acid load on the Mediterranean and a vegan diet: a secondary analysis of a randomized, cross-over trial.jpeg by Hana Kahleova (618836)

    Published 2025
    “…</p>Results<p>Compared with no change on the Mediterranean diet, PRAL and NEAP significantly decreased on the vegan diet; effect sizes: −25.8 (95% CI −34.1 to −17.5); p < 0.001; and −27.1 (95% CI −35.4 to −18.7); p < 0.001, respectively. …”
  18. 7858

    Table 1_Dietary acid load on the Mediterranean and a vegan diet: a secondary analysis of a randomized, cross-over trial.docx by Hana Kahleova (618836)

    Published 2025
    “…</p>Results<p>Compared with no change on the Mediterranean diet, PRAL and NEAP significantly decreased on the vegan diet; effect sizes: −25.8 (95% CI −34.1 to −17.5); p < 0.001; and −27.1 (95% CI −35.4 to −18.7); p < 0.001, respectively. …”
  19. 7859

    <b>Morin alleviates fructose-driven disturbance of podocyte mitochondrial energy metabolism by inhibiting AMPD activity to improve glomerular injury</b> by Luyi Huang (22583081)

    Published 2025
    “…<p dir="ltr">High consumption of fructose is a significant risk factor for glomerular podocyte injury. …”
  20. 7860

    Data Sheet 1_Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11.docx by Ling Li (38566)

    Published 2025
    “…Bryostatin-1 upregulated TCF-1 and decreased TOX expression. These changes were confirmed through RNA-seq analysis. …”